Mari F.C.M. van den Hout

Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria

Augustinus P. T. van der Ploeg, Alexander C. J. van Akkooi, Piotr Rutkowski et al. · Journal of Clinical Oncology · 2011 · 209 citations · Full text

Medicine, Oncology, Surgery +17

Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)

Emma J. de Ruiter, Frans J. Mulder, Bregje M Koomen et al. · Modern Pathology · 2020 · 143 citations · Full text

Medicine, Oncology, Pathology +12

Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation

Rieneke van de Ven, Mari F.C.M. van den Hout, Jelle J. Lindenberg et al. · Blood · 2011 · 92 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials

Bas D. Koster, Mari F.C.M. van den Hout, Berbel J.R. Sluijter et al. · Clinical Cancer Research · 2017 · 64 citations · Full text

Medicine, Immunology, Oncology +17

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation

Berbel J.R. Sluijter, Mari F.C.M. van den Hout, Bas D. Koster et al. · Cancer Immunology Research · 2015 · 63 citations

Life Sciences, Immunology, Oncology +17